USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences

USPTO PatentsView assignee record - 10 granted patents across 18 technology areas, active 2019–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS).

10
Total patents granted
18
CPC technology areas
7.9
Avg claims per patent
+300%
5-year filing velocity

The verdict

Qingdao holds 10 US patents across 18 technology areas, rank #27,194 of 50,000 tracked assignees.

#27,194
of 50,000 US assignees by volume
Top 45%
by Innovation Score (36.9/100)
7.9
avg claims per patent
+300%
filing velocity, last 5 yrs

Portfolio overview

Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences has been granted 10 US utility patents between 2019 and 2025, placing Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences at rank #27,194 across all assignees tracked by PlainPatent. This portfolio spans 18 distinct Cooperative Patent Classification (CPC) subclasses, averaging 7.9 claims per patent with primary concentration in B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS). As a Foreign Corporation, Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences is one of the more focused assignees in the PatentsView dataset. By volume, Qingdao sits between Pulmatrix Operating Company, Inc. (10 patents, rank #27,190) and Qualipac (10 patents, rank #27,198) - the closest US assignees by grant volume. The composite Innovation Score of 36.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 2 in the 2015–2019 window, a +300% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's 7.9 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 18 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences against peers pursuing similar technology classes.

Who files at Qingdao's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Qingdao holds 10 patents at rank #27,194, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Qingdao

By rank, the assignees closest to #27,194 in granted patent volume.

Leaders in B01J (Chemical OR Physical Processes)

Other assignees with the most granted patents in Qingdao's primary technology class.

Qingdao's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

37 Top 45% higher than 55% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). This entry sits in this band. 40–50: 11,491 US assignees (23%). Above this entry. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20192021202320242025 3
USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 2 20.0%
2021 1 10.0%
2023 3 30.0%
2024 1 10.0%
2025 3 30.0%

Which technologies does Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences patent most?

Top 15 of 18 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Simple
Velocity Accelerating

Where it ranks

Overall rank by patents

#27,194

Across all tracked assignees

Innovation Score

36.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences hold?
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences holds 10 US granted patents filed between 2019 and 2025, spanning 18 technology areas.
What is Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's Innovation Score?
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences has an Innovation Score of 36.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences focus on?
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's top technology area is B01J (CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS) with 4 patents. The company has filed patents in 18 CPC subclasses total.
Is Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's patent filing rate increasing or decreasing?
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's recent filing velocity is +300% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's patents?
Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences's patents average 7.9 claims each. This is relatively simple claim structure, typical for focused inventions.
How is the Qingdao Institute OF Bioenergy AND Bioprocess Technology, Chinese Academy OF Sciences patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Qingdao's 10 grants land it in the top 45% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Qingdao ranks #27,194 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in B01J - see who else leads that technology area. B01J leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.